NEXGEL, Inc. NXGL
At closeNov 4, 2026, 7:43 AM EST
Pre-market · Nov 4, 7:43 AM ET
- YTD
- -86.09%
- 1 year
- -89.82%
- Market cap
- 2.18M
- Revenue (ttm)
- 5.01M
- Profit margin
- -67.60%
- EPS (ttm)
- -14.80
- Shares out
- 6.79M
- Forward P/E
- 116.50
- YTD return
- -86.09%
- 1-year return
- -89.82%
- Volume
- 22.15K
- Avg volume
- 112.76K
- Open
- 3.80
- Previous close
- 3.74
- Day's range
- 3.69 – 4.48
- 52-week range
- 3.00 – 53.60
- Beta
- 0.73
- Price target
- 6.00 (+33.9%)
2Y -54.42 (-92.39%)
Key statistics
- Enterprise value
- 22.40M
- PEG ratio
- 0.00
- Price / sales
- 6.32
- Price / book
- 5.70
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 23.40%
- Free cash flow
- -1.89M
- Total cash
- 1.07M
- Total debt
- 3.00M
- Return on equity
- -64.31%
- Short % of float
- 0.53%
- 50-day average
- 3.37
- 200-day average
- 2.67
Analyst view
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.10.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.11 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -0.14 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.14 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -0.19 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.10 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -0.12 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 25, 2022 | Maxim Group | init | — | Buy |
About NEXGEL, Inc.
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- nexgel.com
News
NEXGEL Regains Nasdaq Compliance 
12 Health Care Stocks Moving In Monday's After-Market Session 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
Why Ericsson Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket 
NEXGEL Announces 1-For-20 Reverse Stock Split, Effective Immediately 
12 Health Care Stocks Moving In Wednesday's After-Market Session - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Your note
Sign in to keep a note on NXGL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DRAPCZUK ADAM III | Chief Financial Officer | Purchase | Nov 19, 2024 | 0 |
| GLASSMAN STEVEN MARK | Director | Purchase | Nov 19, 2024 | 154,155 |
| HENRY SCOTT ROBERT | Director | Purchase | Nov 19, 2024 | 147,553 |
| LEVY ADAM R | Chief Executive Officer | Purchase | Nov 19, 2024 | 333,196 |
| STEFANSKY DAVID | Director | Purchase | Jun 7, 2023 | 228,663 |
| STEIN JOHN NACHUM | Director | Purchase | Nov 19, 2024 | 471,456 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.84% | 56,840 | 264.87K | Sep 29, 2024 |
| Vanguard Group Inc | 0.74% | 49,975 | 232.88K | Sep 29, 2024 |
| Simon Quick Advisors, LLC | 0.53% | 35,715 | 166.43K | Sep 29, 2024 |
| Northeast Financial Group, Inc. | 0.47% | 31,848 | 148.41K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.42% | 28,455 | 132.60K | Sep 29, 2024 |
| NewEdge Advisors, LLC | 0.28% | 19,291 | 89.90K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.49% | 33,311 | 155.23K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.38% | 25,526 | 118.95K | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 0.36% | 24,449 | 113.93K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.20% | 13,702 | 63.85K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 7,799 | 36.34K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 546 | 2.54K | Oct 30, 2024 |